These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 28343423

  • 1. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
    Franchitto N, Jullian B, Salles J, Pelissier F, Rolland B.
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):669-677. PubMed ID: 28343423
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.
    Yéléhé-Okouma M, Martini H, Lemarié J, Labroca P, Petitpain N, Gibaja V, Paille F, Gillet P.
    Fundam Clin Pharmacol; 2017 Oct; 31(5):574-579. PubMed ID: 28322465
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction.
    Diot C, Eiden C, Roussin A, Batisse A, Boucher A, Chavant F, Daveluy A, Donadieu-Rigole H, Peyrière H, réseau des centres français d’addictovigilance.
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1539-40. PubMed ID: 26329380
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acute opioid withdrawal precipitated by ingestion of crushed embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literature.
    Ruan X, Chen T, Gudin J, Couch JP, Chiravuri S.
    J Opioid Manag; 2010 Dec; 6(4):300-3. PubMed ID: 20862910
    [Abstract] [Full Text] [Related]

  • 11. Antagonist treatment of opioid withdrawal translational low dose approach.
    Mannelli P, Gottheil E, Van Bockstaele EJ.
    J Addict Dis; 2006 Dec; 25(2):1-8. PubMed ID: 16785213
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.
    Fishman M.
    Addiction; 2008 Aug; 103(8):1399-401. PubMed ID: 18855831
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience about an unexpected adverse event during nalmefene treatment in two patients with alcohol use disorder.
    Milano G, Zavan V, Natta WM, Martelli A, Mattioli F.
    J Clin Pharm Ther; 2016 Feb; 41(1):97-100. PubMed ID: 26714742
    [Abstract] [Full Text] [Related]

  • 16. [Nalmefene: a novel pharmacotherapeutic option for alcoholism].
    Soyka M.
    Nervenarzt; 2014 May; 85(5):578-82. PubMed ID: 24126432
    [Abstract] [Full Text] [Related]

  • 17. Assessment of nalmefene glucuronide as a selective gut opioid antagonist.
    Cheskin LJ, Chami TN, Johnson RE, Jaffe JH.
    Drug Alcohol Depend; 1995 Aug; 39(2):151-4. PubMed ID: 8529534
    [Abstract] [Full Text] [Related]

  • 18. Safety of nalmefene for the treatment of alcohol use disorder: an update.
    López-Pelayo H, Zuluaga P, Caballeria E, Van den Brink W, Mann K, Gual A.
    Expert Opin Drug Saf; 2020 Jan; 19(1):9-17. PubMed ID: 31868031
    [Abstract] [Full Text] [Related]

  • 19. Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report.
    Szczesniak LM, Calleo VJ, Sullivan RW.
    Harm Reduct J; 2020 Oct 07; 17(1):71. PubMed ID: 33028340
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.